Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Human VEGF R3 ELISA Kit (ab252350)

Human VEGF R3 ELISA Kit (ab252350)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • One-wash 90 minute protocol
  • Sensitivity: 89.6 pg/ml
  • Range: 218.8 pg/ml - 14000 pg/ml
  • Sample type: Cell culture media, Cit plasma, EDTA Plasma, Hep Plasma, Serum
  • Detection method: Colorimetric
  • Assay type: Sandwich (quantitative)
  • Reacts with: Human

You may also be interested in

Anti-D Amino Acid Oxidase antibody (ab187525)
Product image
Anti-Calpain 5 antibody (ab97534)
Product image
Anti-Eph receptor B4/HTK antibody [EPR23222-24] (ab254301)
Product image
Anti-RAGEF2 antibody (ab86225)

Overview

  • Product name

    Human VEGF R3 ELISA Kit
    See all VEGF Receptor 3 kits
  • Detection method

    Colorimetric
  • Precision

    Intra-assay
    Sample n Mean SD CV%
    Serum 8 2.3%
    Inter-assay
    Sample n Mean SD CV%
    Serum 3 3%
  • Sample type

    Serum, Cell culture media, Hep Plasma, EDTA Plasma, Cit plasma
  • Assay type

    Sandwich (quantitative)
  • Sensitivity

    89.6 pg/ml
  • Range

    218.8 pg/ml - 14000 pg/ml
  • Recovery

    Sample specific recovery
    Sample type Average % Range
    Serum 96 88% - 101%
    Cell culture media 103 98% - 105%
    Hep Plasma 106 104% - 107%
    EDTA Plasma 96 80% - 106%
    Cit plasma 91 82% - 106%
  • Assay time

    1h 30m
  • Assay duration

    One step assay
  • Species reactivity

    Reacts with: Human
    Does not react with: Cow
  • Product overview

    Human VEGF R3 ELISA Kit (ab252350) is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of VEGF R3 protein in cell culture media, cit plasma, edta plasma, hep plasma, and serum. It uses our proprietary SimpleStep ELISA® technology. Quantitate Human VEGF R3 with 89.6 pg/ml sensitivity.


    SimpleStep ELISA® technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details. Our SimpleStep ELISA® technology provides several benefits:


            - Single-wash protocol reduces assay time to 90 minutes or less
            - High sensitivity, specificity and reproducibility from superior antibodies
            - Fully validated in biological samples
            - 96-wells plate breakable into 12 x 8 wells strips


    A 384-well SimpleStep ELISA® microplate (ab203359) is available to use as an alternative to the 96-well microplate provided with SimpleStep ELISA® kits.

  • Platform

    Pre-coated microplate (12 x 8 well strips)

Properties

  • Storage instructions

    Store at +4°C. Please refer to protocols.
  • Components 1 x 96 tests
    10X Human VEGF R3 Capture Antibody 1 x 600µl
    10X Human VEGF R3 Detector Antibody 1 x 600µl
    10X Wash Buffer PT (ab206977) 1 x 20ml
    Antibody Diluent 4BI 1 x 6ml
    Human VEGF R3 Lyophilized Recombinant Protein 2 vials
    Plate Seals 1 unit
    Sample Diluent NS (ab193972) 1 x 50ml
    SimpleStep Pre-Coated 96-Well Microplate (ab206978) 1 unit
    Stop Solution 1 x 12ml
    TMB Development Solution 1 x 12ml
  • Research areas

    • Cardiovascular
    • Angiogenesis
    • Growth Factors
    • VEGF
    • VEGF Receptors
    • Signal Transduction
    • Protein Phosphorylation
    • Tyrosine Kinases
    • Receptor Tyrosine Kinases
    • Signal Transduction
    • Growth Factors/Hormones
    • VEGF
    • Cancer
    • Growth factors
    • VEGF
    • Cancer
    • Invasion/microenvironment
    • Angiogenesis
    • Angiogenic growth factors
    • Cancer
    • Oncoproteins/suppressors
    • Oncoproteins
    • Growth factor receptors
    • Cardiovascular
    • Angiogenesis
    • Endothelial Cell Markers
  • Function

    Receptor for VEGFC. Has a tyrosine-protein kinase activity.
  • Tissue specificity

    Placenta, lung, heart, and kidney, does not seem to be expressed in pancreas and brain.
  • Involvement in disease

    Defects in FLT4 are the cause of lymphedema hereditary type 1A (LMPH1A) [MIM:153100]; also known as Nonne-Milroy lymphedema or Milroy disease. Hereditary lymphedema is a chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment.
    Note=Defects in FLT4 are found in juvenile hemangioma. Juvenile hemangiomas are the most common tumors of infancy, occurring as many as 10% of all births. These benign vascular lesions enlarge rapidly during the first year of life by hyperplasia of endothelial cells and attendant pericytes, and then spontaneously involute over a period of years, leaving loose fibrofatty tissue.
  • Sequence similarities

    Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
    Contains 7 Ig-like C2-type (immunoglobulin-like) domains.
    Contains 1 protein kinase domain.
  • Cellular localization

    Membrane.
  • Target information above from: UniProt accession P35916 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Alternative names

    • EC 2.7.10.1
    • flt 4
    • FLT-4
    • FLT4
    • FLT41
    • Fms related tyrosine kinase 4
    • Fms-like tyrosine kinase 4
    • LMPH1A
    • PCL
    • Soluble VEGFR3 variant 1
    • Soluble VEGFR3 variant 2
    • Soluble VEGFR3 variant 3
    • Tyrosine protein kinase receptor FLT4
    • Tyrosine-protein kinase receptor FLT4
    • Vascular endothelial growth factor receptor 3
    • Vascular endothelial growth factor receptor 3 precursor
    • VEGF R3
    • VEGFR 3
    • VEGFR-3
    • VEGFR3
    • VGFR3_HUMAN
    see all
  • Database links

    • Entrez Gene: 2324 Human
    • Omim: 136352 Human
    • SwissProt: P35916 Human
    • Unigene: 646917 Human

    Images

    • Other - Human VEGF R3 ELISA Kit (ab252350)
      Other - Human VEGF R3 ELISA Kit (ab252350)

      SimpleStep ELISA technology allows the formation of the antibody-antigen complex in one single step, reducing assay time to 90 minutes. Add samples or standards and antibody mix to wells all at once, incubate, wash, and add your final substrate. See protocol for a detailed step-by-step guide.

       

    • Example of human VEGF R3 standard curve in Sample Diluent NS.
      Example of human VEGF R3 standard curve in Sample Diluent NS.

      The VEGF R3 standard curve was prepared as described in Section 10. Raw data values are shown in the table. Background-subtracted data values (mean +/- SD) are graphed.

    • Interpolated concentrations of native VEGF R3 in human serum and plasma samples.
      Interpolated concentrations of native VEGF R3 in human serum and plasma samples.

      The concentrations of VEGF R3 were measured in duplicates, interpolated from the VEGF R3 standard curves and corrected for sample dilution. Undiluted samples are as follows: serum 5%, plasma (citrate) 5%, plasma (heparin) 5%, and plasma (EDTA) 5%. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean VEGF R3 concentration was determined to be 215.0 ng/mL in neat serum, 185.8 ng/mL in neat plasma (citrate), 197.9 ng/mL in neat plasma (heparin), and 191.5 ng/mL in neat plasma (EDTA).

    • Serum from ten individual healthy human female donors was measured in duplicate.
      Serum from ten individual healthy human female donors was measured in duplicate.

      Interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean VEGF R3 concentration was determined to be 294.2 ng/mL with a range of 197.4 – 429.6 ng/mL.

    • Sandwich ELISA - Human VEGF R3 ELISA Kit (ab252350)
      Sandwich ELISA - Human VEGF R3 ELISA Kit (ab252350)
      To learn more about the advantages of recombinant antibodies see here.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Alternative products to Human VEGF R3 ELISA Kit (ab252350)

    •  
    • Product image

      Human VEGF R3 Antibody Pair - BSA and Azide free (ab256695)

      Applications:

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-ATP6V0D1/P39 antibody [EPR18320-38] (ab202899)

    •  
    • Product image

      Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (ab109450)

    •  
    • Product image

      Anti-Eph receptor B1/NET antibody [EPR6457] (ab129103)

    •  
    • Product image

      Anti-POLD1 antibody [EPR15118] - BSA and Azide free (ab240300)

    •  
    • Product image

      Anti-Alpha B Crystallin antibody [EPR2752] - BSA and Azide free (ab247476)

    •  
    • Product image

      Anti-Anti-CRISPR protein AcrIIA4 antibody [7C5-3A8] (ab273439)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.